Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia

Lancet

Volumn 350, Issue 9087, 1997, Pages 1267-1271

  Steyn, D Wilhelm ^a   Odendaal, Hein J ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; KETANSERIN; SEROTONIN; SEROTONIN 2 RECEPTOR; THROMBOXANE A2;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031560185     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06408-8     Document Type: Article

References (26)

1. DHSS. Report on confidential inquiries into maternal deaths in the United Kingdom 1985-1987. London: HMSO, 17-27.
2. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, latin America, and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547-53.
3. Moore MP, Redman CWG. Case control study of severe pre-eclampsia of early onset. BMJ 1983; 287: 580-83.
4. Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe pre-eclampsia in midtrimester. Am J Obstet Gynecol 1985; 152: 32-37.
5. Pattinson RC, Odendaal HJ, Du Toit R. Conservative management of severe proteinuric hypertension before 28 weeks' gestations. S Afr Med J 1988; 73: 516-18.
6. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-04.
7. Dekker GA. The pharmacological prevention of pre-eclampsia. Baillieres Clin Obstet Gynaecol 1995; 9: 509-28.
8. Viinikka L, Hartikainen-Sorri A-L, Lumme R, Hiilesma V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacycline: thromboxane balance in mother and newborn. Br J Obstet Gynaecol 1933; 100: 809-15.
9. CLASP (Collaborative low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994; 343: 619-29.
10. Middlelkoop CM, Dekker GA, Kraayenbrink AA, Popp-Snijders C. Platelet poor plasma serotonin in normal and preeclamptic pregnancy. Clin Chem 1993; 39: 1675-78.
11. Dekker GA, Van Geijn HP. Endothelial dysfunction in preeclampsia, part II: reducing the adverse consequences of endothelial cell dysfunction in preeclampsia - therapeutic perspectives. J Perinat Med 1996: 24: 119-39.
12. Chari RS, Friedman SA, Sibai BM. Antihypertensive therapy during pregnancy. Fetal Mat Med Rev 1995; 7: 61-75.
13. Duley L. Any hypertensive therapy in chronic hypertension. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C, eds. Pregnancy and childb orth module. In: Cochrane Library (CDROM and online): Cochrane Collaboration, Issue 2. Oxford: Update Software, 1995.
14. Odendaal HJ, Schabort I, Pattinson RC. Prazosin for the treatment of hypertension in pregnancy: a randomised controlled trial. In: Oxford Database of Perinatal Trials, Version 1.2, Disk Issue 6, Autumn. Chalmers I, ed. Oxford: Oxford University Press, 1991.
15. Frishman WH, Huberfeld S, Okin S, Wang Y-H, Kumar A, Shareef B. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J Clin Pharmacol 1995; 35: 541-72.
16. Weiner CP, Socol ML, Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am J Obstet Gynecol 1984; 149: 496-500.
17. Hulme VA, Odendaal HJ. Intrapartum treatment of preeclamptic hypertension by ketanserin. Am J Obstet Gynecol 1986; 155: 260-63.
18. De Clerck F, Xhonneu x B. Continuous inhibition of platelet S2 serotonergic receptors during chronic administration of ketanserin in humans. J Cardiovasc Pharmacol 1985; 7: S23-25.
19. Dzurik R, Fetkovska N, Brimichova G, Tison P. Blood pressure, 5-Oh indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin. J Cardiovasc Pharmacol 1985; 7: S29-31.
20. Franx A, Van der Post J, Elfering I, et al. Validation of automated blood pressure recording in pregnancy. Br J Obstet Gynaecol 1994; 101: 66-69.
21. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynaecol 1988; 158: 892-98.
22. Odendaal HJ, Steyn DW, Norman K, Kirsten GF, Smith J, Theron GB. Improved perinatal outcome in 1001 patients with severe pre-eclampsia. S Afr Med J 1995; 85: 1071-76.
23. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R. Maternal fetal medicine: principles and practice. Philadelphia: WB Saunders, 1994; 804-43.
24. 2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs. Cardiovasc Res 1993; 23; 1374-79.
25. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1689-1712.
26. MacGillivray I, Rose GA, Rowe B. Blood pressure survey in pregnancy. Clin Sci 1969; 37: 395-407.